Robert Bedingfield - Science Applications Independent Director
| SAIC Stock | USD 115.87 0.79 0.68% |
Director
Mr. Robert A. Bedingfield serves as Independent Director of the Company. Until his retirement in June 2013, Mr. Bedingfield was a Global Coordinating Partner at Ernst Young LLP with over 40 years of experience, including 32 years as a partner in EYs accounting and auditing practices. He previously served as EYs Aerospace Defense Practice Leader for over 15 years. He also served as Senior Advisory Partner for a number of EYs largest clients and served on EYs Senior Governing Board. Mr. Bedingfield was a Trustee of the University of Maryland at College Park Board of Trustees since 2000 and has served on its Executive Committee and as Chair of its Audit Committee. Since March 2015, Mr. Bedingfield has also been a member of the Board of Directors of GeoPark Limited, a Latin American oil and gas explorer, operator and consolidator. since 2013.
| Age | 71 |
| Tenure | 12 years |
| Address | 12010 Sunset Hills Road, Reston, VA, United States, 20190 |
| Phone | 703 676 4300 |
| Web | https://www.saic.com |
Science Applications Management Efficiency
The company has return on total asset (ROA) of 0.0583 % which means that it generated a profit of $0.0583 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1672 %, meaning that it created $0.1672 on every $100 dollars invested by stockholders. Science Applications' management efficiency ratios could be used to measure how well Science Applications manages its routine affairs as well as how well it operates its assets and liabilities. At present, Science Applications' Return On Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.28, whereas Return On Tangible Assets are forecasted to decline to 0.11. At present, Science Applications' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 1.4 B, whereas Total Assets are forecasted to decline to about 4.7 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Ajay Agrawal | Genpact Limited | 51 | |
| Gary May | Leidos Holdings | 56 | |
| Harry Kraemer | Leidos Holdings | 66 | |
| Michael Menezes | WNS Holdings | 67 | |
| Keith Haviland | WNS Holdings | 61 | |
| Frank Kendall | Leidos Holdings | 71 | |
| Gareth Williams | WNS Holdings | 67 | |
| Steven Leer | Parsons Corp | 67 | |
| Mark Verdi | Genpact Limited | 54 | |
| Gregory Johnson | CACI International | 74 | |
| Jason Liberty | WNS Holdings | 45 | |
| Darren McDew | Parsons Corp | 60 | |
| Susan Stalnecker | Leidos Holdings | 68 | |
| James Pavitt | CACI International | 74 | |
| Francoise Gri | WNS Holdings | 62 | |
| Warren Phillips | CACI International | 78 | |
| Mariel Joliet | ASGN Inc | 54 | |
| David Wajsgras | Parsons Corp | 60 | |
| Tamara Franklin | Genpact Limited | 54 | |
| Brian Callaghan | ASGN Inc | 49 | |
| Stephen Pagliuca | Gartner | 65 | |
Management Performance
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0583 |
Science Applications Leadership Team
Elected by the shareholders, the Science Applications' board of directors comprises two types of representatives: Science Applications inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Science. The board's role is to monitor Science Applications' management team and ensure that shareholders' interests are well served. Science Applications' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Science Applications' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dorothy Helfenstein, Executive Vice President Chief Strategic Growth Officer | ||
| Yvette Kanouff, Independent Director | ||
| Steven Mahon, Executive Vice President, General Counsel, Secretary | ||
| Donna Morea, Non-Executive Independent Chairman of the Board | ||
| Nathan Rogers, Chief Officer | ||
| Hilary Hageman, General VP | ||
| Joseph DeNardi, Senior Treasurer | ||
| John Bonsell, Senior Affairs | ||
| Prabu Natarajan, Chief Financial Officer, Executive Vice President | ||
| Garth Graham, Independent Director | ||
| Robert Genter, Executive Vice President and General Manager - Civilian Markets Group | ||
| Nazzic Keene, Sector President of Global Markets and Missions | ||
| Mark Escobar, Executive Operations | ||
| Robert Bedingfield, Independent Director | ||
| Steven Shane, Independent Director | ||
| Milford McGuirt, Director | ||
| Josh Jackson, Executive Unit | ||
| Hilary JD, General VP | ||
| Catherine HernandezBlades, Senior Communications | ||
| Michelle OHara, Chief Human Resource Officer, Executive Vice President | ||
| Paul Greiner, Senior Counsel | ||
| Michael LaRouche, Executive Vice President and General Manager - National Security Group | ||
| Toni TownesWhitley, CEO Director | ||
| Lucy Fitch, Chief VP | ||
| Maria Bishop, Senior Controls | ||
| Katharina McFarland, Independent Director | ||
| Carol Goode, Independent Director | ||
| John Hamre, Independent Director | ||
| Timothy Mayopoulos, Independent Director |
Science Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Science Applications a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0583 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 7.97 B | ||||
| Shares Outstanding | 48.88 M | ||||
| Shares Owned By Insiders | 0.96 % | ||||
| Shares Owned By Institutions | 77.37 % | ||||
| Number Of Shares Shorted | 943.25 K | ||||
| Price To Earning | 30.77 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is IT Consulting & Other Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Applications. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Applications listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Earnings Share 5.9 | Revenue Per Share | Quarterly Revenue Growth 0.019 | Return On Assets |
The market value of Science Applications is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Applications' value that differs from its market value or its book value, called intrinsic value, which is Science Applications' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Applications' market value can be influenced by many factors that don't directly affect Science Applications' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Science Applications' value and its price as these two are different measures arrived at by different means. Investors typically determine if Science Applications is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Applications' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.